Trial Profile
Phase I trial of HS 25, a statin compound to treat primary hypercholesterolaemia and nephrotic hyperlipidaemia
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 24 Mar 2014
Price :
$35
*
At a glance
- Drugs Hyzetimibe (Primary)
- Indications Hypercholesterolaemia; Hyperlipidaemia
- Focus Adverse reactions
- 24 Mar 2014 Status changed from planning to completed.
- 24 Mar 2014 New trial record